Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Inhalon’s inhaled antibody therapy aims to address this need, the release said. Its RSV candidate is part of a more broad effort to develop therapies that deliver therapeutic antibodies directly to ...

The recent surge in influenza cases in the Triad and statewide has led to an increase in flu-related deaths, including two ...

Scientists have uncovered a blood-based molecular signature that can predict vaccine durability. Could this change ...

Influenza A Viruses Adapt Shape in Response to Environmental Pressures - NIH Study Identifies Previously Unknown Adaptation ...

Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application ...

Is it common for the flu to zap us twice in the winter months? Massachusetts, and the U.S. for that matter, had a surge in ...

Several viruses are circulating around the globe, including in Utah. But because there’s limited information on some of them, ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

ENA Respiratory, a clinical-stage pharmaceutical company developing antiviral host defence immune enhancers to minimize the impact of viral respiratory infections, announces today it has received a ...

Flu cases are surging this winter—this season is no joke. New data from the Centers for Disease Control and Prevention ...

The worst flu season in years is swamping California, prompting a renewed surge in hospitalizations as officials warn the ...